January 15, 2016
Vice Health Minsiter Kazuo Futagawa Research-oriented drug makers should consider transforming their business models if they find it difficult to keep bringing out innovative drugs, possibly by turning into generic makers, Kazuo Futagawa, the health ministry’s highest-ranking bureaucrat, said. With...read more